Aeterna Zentaris
AEZS
#10161
Rank
HK$0.13 B
Marketcap
HK$44.84
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Aeterna Zentaris (AEZS)

Earnings in 2024 (TTM): -HK$42.88 Million

According to Aeterna Zentaris's latest financial reports the company's current earnings are HK$6.32 Million. In 2023 the company made an earning of -HK$26.23 Million a decrease over its 2022 earnings that were of HK$28.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aeterna Zentaris from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$42.88 Million63.47%
2023 -HK$26.23 Million-193.05%
2022 HK$28.18 M118.42%
2021 HK$12.9 M66.11%
2020 HK$7.76 M-251.06%
2019 -HK$5.15 Million25.51%
2018 -HK$4.1 Million72.53%
2017 -HK$2.38 Million-109.78%
2016 HK$24.28 M49.97%
2015 HK$16.19 M61.77%
2014 HK$10.01 M597.94%
2013 HK$1.43 M-134.11%
2012 -HK$4.21 Million-182.25%
2011 HK$5.11 M-50.2%
2010 HK$10.26 M1084.23%
2009 HK$0.86 M-109.18%
2008 -HK$9.45 Million-6.23%
2007 -HK$10.08 Million752.47%
2006 -HK$1.19 Million269.03%
2005 -HK$0.33 Million-84.64%
2004 -HK$2.09 Million9.96%
2003 -HK$1.9 Million184.21%
2002 -HK$0.67 Million-69.93%
2001 -HK$2.22 Million-22.76%
2000 -HK$2.88 Million-13.94%
1999 -HK$3.34 Million-31.33%
1998 -HK$4.86 Million-84.12%
1997 -HK$30.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$128.17 B-298,195.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$71.33 B-165,996.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$62.96 B-146,540.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$0.49 Billion 1,028.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$5.84 B-13,698.38%๐Ÿ‡บ๐Ÿ‡ธ USA